Purpura
Showing 26 - 50 of 1,747
Idiopathic Thrombocytopenic Purpura Trial in Wuhan, Chengdu, Tianjin (Hetrombopag Olamine, matching )
Completed
- Idiopathic Thrombocytopenic Purpura
- Hetrombopag Olamine
- matching placebo
-
Wuhan, Hubei, China
- +2 more
Aug 2, 2022
Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)
Active, not recruiting
- Idiopathic Thrombocytopenic Purpura
- R788
- Placebo
-
Multiple Locations, JapanResearch Site
Mar 22, 2022
Improvement of Immunologic and Molecular Techniques for
Not yet recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
- ADAMTS13 Activity Assays
- (no location specified)
May 26, 2022
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Some Cytokines Expression in ITP Primary Immune Thrombocytopenic
Recruiting
- Primary Immune Thrombocytopenia
- Plasma RNA isolation, qPCR analysis of micro RNA
- +2 more
-
Sohag, EgyptSohag University
May 7, 2022
Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)
Enrolling by invitation
- Lupus Erythematosus, Systemic
- +3 more
- rapid GCs taper
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Aug 16, 2022
Immune Thrombocytopenia Trial in Hong Kong (Eltrombopag)
Suspended
- Immune Thrombocytopenia
-
Hong Kong, Hong Kong SAR, Hong KongHumanity & Health Research Centre
Mar 16, 2022
Method With Gradient Glycosylation by Mass Spectrometry
Active, not recruiting
- Rheumatoid Purpura
- Pediatric ALL
- Mass Sepctrometry
-
Montpellier, France
- +1 more
Mar 8, 2022
Platelets Sialylation by Flow Cytometry for Differential
Completed
- Idiopathic Thrombocytopenic Purpura
- non interventional study
-
Nantes, FranceNantes University Hospital
Jan 17, 2022
Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies
Completed
- Idiopathic Purpura
-
Montpellier, FranceUhmontpellier
Oct 22, 2021
Thrombotic Thrombocytopenic Purpura Trial in Paris (Sulfate, Magnesium, Placebo - Concentrate)
Active, not recruiting
- Thrombotic Thrombocytopenic Purpura
- Sulfate, Magnesium
- Placebo - Concentrate
-
Paris, FranceSaint Louis hospital
Oct 28, 2021
Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)
Not yet recruiting
- Purpura, Thrombocytopenic, Idiopathic
- all-trans retinoic acid
- Eltrombopag
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jun 25, 2022
TTP Patients: Italian Experience (ROSCAPLI)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura, Acquired
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli, IRCCS
Feb 21, 2022
T Cells and Natural Killer Cells Expression in Immune
Not yet recruiting
- Immune Thrombocytopenic Purpura
- Laboratory investigations for control
- Laboratory investigations for patients
- (no location specified)
Oct 13, 2021
Efficiency of Caplacizumab in the Treatment of aTTP
Recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
-
Cologne, GermanyUniversity Hospital of Cologne
Dec 28, 2021
Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)
Completed
- Thrombocytopenia Purpura
- Chronic HBV Infection
-
Tianjin, Tianjin, ChinaEthics Committee of Blood disease hospital, Chinese Academy of M
Jan 24, 2023
Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)
Not yet recruiting
- Immune Thrombocytopenia
- peripheral blood and bone marrow withdrawal
- (no location specified)
Jan 12, 2023
Congenital Thrombotic Thrombocytopenic Purpura Trial in Worldwide (TAK-755)
Recruiting
- Congenital Thrombotic Thrombocytopenic Purpura
- TAK-755
-
Atlanta, Georgia
- +20 more
Mar 29, 2022
Idiopathic Thrombocytopenic Purpura Trial in Worldwide (Romiplostim)
Completed
- Idiopathic Thrombocytopenic Purpura
- Romiplostim
-
Anaheim, California
- +47 more
Sep 8, 2022
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)
Enrolling by invitation
- Idiopathic Thrombocytopenic Purpura
- GNR-069
-
Irkutsk, Irkutsk Region, Russian Federation
- +12 more
Aug 5, 2022
Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura, Acquired
- Bortezomib Injection
-
Beijing, (Select), ChinaPeking Union Medical College Hospital
Nov 22, 2021